These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 23380809)
1. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809 [TBL] [Abstract][Full Text] [Related]
2. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis. Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912 [TBL] [Abstract][Full Text] [Related]
3. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study. Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells. Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698 [TBL] [Abstract][Full Text] [Related]
5. Microarray profiling of circular RNAs in human papillary thyroid carcinoma. Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173 [TBL] [Abstract][Full Text] [Related]
6. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Zhang J; Liu Y; Liu Z; Wang XM; Yin DT; Zheng LL; Zhang DY; Lu XB Int J Med Sci; 2013; 10(5):585-92. PubMed ID: 23533107 [TBL] [Abstract][Full Text] [Related]
8. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622 [TBL] [Abstract][Full Text] [Related]
9. Identification of key genes and miRNAs markers of papillary thyroid cancer. Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611 [TBL] [Abstract][Full Text] [Related]
10. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma. Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081 [TBL] [Abstract][Full Text] [Related]
11. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287 [TBL] [Abstract][Full Text] [Related]
12. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses. Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226 [TBL] [Abstract][Full Text] [Related]
13. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features. Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer. Liang W; Xie Z; Cui W; Guo Y; Xu L; Wu J; Guan H J Cancer Res Clin Oncol; 2017 Apr; 143(4):601-611. PubMed ID: 27942860 [TBL] [Abstract][Full Text] [Related]
15. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma. Li M; Song Q; Li H; Lou Y; Wang L PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287 [TBL] [Abstract][Full Text] [Related]
16. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295 [TBL] [Abstract][Full Text] [Related]
17. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
18. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC. Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA Profiling in Papillary Thyroid Cancer. Armos R; Bojtor B; Papp M; Illyes I; Lengyel B; Kiss A; Szili B; Tobias B; Balla B; Piko H; Illes A; Putz Z; Kiss A; Toth E; Takacs I; Kosa JP; Lakatos P Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273308 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer. Nan BY; Xiong GF; Zhao ZR; Gu X; Huang XS Biomed Res Int; 2021; 2021():6752141. PubMed ID: 33521130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]